These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Fatal side-effects of continuous propofol infusion in children may be related to malignant hyperthermia. Plötz FB; Waalkens HJ; Verkade HJ; Strengers JL; Knoester H; Mandema JM Anaesth Intensive Care; 1996 Dec; 24(6):724. PubMed ID: 8971326 [No Abstract] [Full Text] [Related]
4. Propofol and malignant hyperthermia susceptibility. Pollock AN; McKenzie AJ; Hodges M; Snoeck MM Anaesth Intensive Care; 1997 Oct; 25(5):583-5. PubMed ID: 9352778 [No Abstract] [Full Text] [Related]
5. [Propofol triggers a marked body temperature increase in a patient with fulminant malignant hyperthermia (MH) without inducing other symptoms of MH]. Murao K; Umegaki T; Masuzawa M; Inoue S; Nakao S; Shingu K Masui; 2010 Jan; 59(1):92-6. PubMed ID: 20077777 [TBL] [Abstract][Full Text] [Related]
6. Effect of propofol on the malignant hyperthermia susceptible pig model. Krivosic-Horber R; Reyfort H; Becq MC; Adnet P Br J Anaesth; 1989 Jun; 62(6):691-3. PubMed ID: 2787665 [TBL] [Abstract][Full Text] [Related]
17. The screening of propofol in MHS swine. Raff M; Harrison GG Anesth Analg; 1989 Jun; 68(6):750-1. PubMed ID: 2786680 [TBL] [Abstract][Full Text] [Related]
18. [The use of propofol in a female patient predisposed to malignant hyperthermia (central core disease)]. Rivolta M; Riedo R; Ostaldo M; Fontana G; Motta F Minerva Anestesiol; 1992 Apr; 58(4):219-21. PubMed ID: 1620420 [TBL] [Abstract][Full Text] [Related]
19. [A case of high dose administration of propofol]. Nishioka H; Kinuwaki H; Shimoda O; Terasaki H Masui; 2000 Oct; 49(10):1142-4. PubMed ID: 11075566 [TBL] [Abstract][Full Text] [Related]
20. No response to trigger agents in a malignant hyperthermia-susceptible patient. Claxton BA; Cross MH; Hopkins PM Br J Anaesth; 2002 Jun; 88(6):870-3. PubMed ID: 12173209 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]